Epigenomics: From Chromatin Biology to Therapeutics

Epigenomics: From Chromatin Biology to Therapeutics

  • £30.29
  • Save £89

Cambridge University Press
Edition: Illustrated, 8/2/2012
EAN 9781107003828, ISBN10: 1107003822

Hardcover, 548 pages, 25.4 x 17.5 x 2.8 cm
Language: English

Understanding mechanisms of gene regulation that are independent of the DNA sequence itself - epigenetics - has the potential to overthrow long-held views on central topics in biology, such as the biology of disease or the evolution of species. High throughput technologies reveal epigenetic mechanisms at a genome-wide level, giving rise to epigenomics as a new discipline with a distinct set of research questions and methods. Leading experts from academia, the biotechnology and pharmaceutical industries explain the role of epigenomics in a wide range of contexts, covering basic chromatin biology, imprinting at a genome-wide level, and epigenomics in disease biology and epidemiology. Details on assays and sequencing technology serve as an up-to-date overview of the available technological tool kit. A reliable guide for newcomers to the field as well as experienced scientists, this is a unique resource for anyone interested in applying the power of twenty-first-century genomics to epigenetic studies.

List of contributors
Part I. Basics of Chromatin Biology and Biochemistry
1. Introduction to epigenomics
2. Epigenetics and its historical perspectives
3. Functional networks of human epigenetic factors
4. Nucleosome positioning in promoters
significance and open questions
5. Chemical reporters of protein methylation and acetylation
6. Long non-coding RNA in epigenetic gene silencing
Part II. Epigenomic Imprinting and Stem Cells
7. Active DNA demethylation - the enigma starts in the zygote
8. Histone modifications of lineage specific genes in human embryonic stem cells during in vitro differentiation
9. Epigenetic stability of human pluripotent stem cells
10. Impact of CpG methylation in addressing adipose derived stem cell differentiation towards the cardiac phenotype
11. Regulation of stem cell epigenome by REST
12. MicroRNAs in embryonic stem cells
13. Regulation of timing of replication
Part III. Epigenomic Assays and Sequencing Technology
14. Detection of CpG methylation patterns by affinity capture methods
15. Genome-wide ChIP-DSL profiling of promoter methylation patterns associated with cancer and stem cell differentiation
16. Quantitative, high-resolution CpG methylation assays on the pyrosequencing platform
17. DNA methylation profiling using Illumina BeadArray platform
18. Advances in capillary electrophoresis-based methods for DNA methylation analysis
19. Genome-wide methylome analysis based on new HT sequencing technology
20. 3-D quantitative DNA methylation imaging for chromatin texture analysis in pharmacoepigenomics and toxicoepigenomics
Part IV. Epigenomics in Disease Biology
21. Cancer classification by genome-wide and quantitative DNA methylation analyses
22. Promoter CpG island methylation in colorectal cancer
biology and clinical applications
23. The epigenetic profile of bladder cancer
24. Genome-scale DNA methylation analyses of cancer in children
25. The epigenetics of facioscapulohumeral muscular dystrophy
26. Modulating histone acetylation with inhibitors and activators
Part V. Epigenomics in Neurodegenerative Diseases
27. Study design considerations in epigenetic studies of neuropsychiatric disease
28. Epigenetic regulation in human neurodevelopmental disorders including autism, Rett syndrome and epilepsy
29. The neurobiology of chromatin-associated mechanisms in the context of psychosis and mood spectrum disorders
30. Genome-wide DNA methylation analysis in patients with familial ATR-X mental retardation syndrome
31. Kinases and phosphatases in the epigenetic regulation of cognitive functions
Part VI. Epigenetic Variation, Polymorphism and Epidemiological Perspectives
32. Epigenetic effects of childhood abuse on the human brain
33. X-linked expressed SNPs and dosage compensation
34. Epigenomic diversity of colorectal cancer
35. Epigenetic epidemiology
transgenerational responses to the environment